newsfilter
← Latest News
Business Wire·

Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and